Torrent Pharmaceuticals Ltd.

1928.35 +62.75 ▲3.4%

29 September 2023, 04:01:00 PM
Volume: 18,343

Company Profile

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.torrentpharma.com
Market Cap 65,264.13 Cr.
Enterprise Value(EV) 69,989.97 Cr. 2023-03
Financial Indicators
Earnings per share (EPS) 37.23 Trailing Twelve Months Ending 2023-06
Price-Earning Ratio (PE) 51.80 Trailing Twelve Months Ending 2023-06
Industry PE 38.47 Trailing Twelve Months Ending 2023-06
Book Value / Share 194.30 Trailing Twelve Months Ending 2023-06
Price to Book Value 9.92 Calculated using Price: 1,928.35
Dividend Yield 1.14 Period Ending 2023-03
No. of Shares Subscribed 33.84 Cr. 338,445,440 Shares
FaceValue 5
About Torrent Pharmaceuticals Ltd.
Torrent Pharmaceuticals has established itself as a major player in the Indian Pharma arena. The company has well segregated marketing divisions, strategically structured on specific therapeutic areas and enjoys dominance in therapeutic segment of cardiovascular (CV), central nervous system (CNS), gastro-intestinal (GI) and women healthcare (WHC). With Unichem's domestic business acquisition, Torrent has entered the list of top pharma firms in the Indian Pharma Market (IPM) and is ranked No 8 in the IPM.

Torrent Pharmaceuticals Ltd. Delivery

Delivered Qty
Traded Qty

Torrent Pharmaceuticals Ltd. Performance

1 Day
+3.36%
1 Week
+2.86%
1 Month
-1.47%
3 Month
-1.28%
6 Month
+24.93%
1 Year
+29.00%
2 Year
+24.20%
5 Year
+133.71%
10 Year
+777.72%

Torrent Pharmaceuticals Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 34.19 57.92 23.80 15.12 9.34 21.47 23.49 13.18 20.50
Return on Capital Employed (%) 26.98 45.63 20.36 13.81 9.75 15.28 17.62 14.35 20.32
Return on Assets (%) 11.71 20.89 10.28 5.81 3.15 7.50 9.20 5.92 9.20

Torrent Pharmaceuticals Ltd. Balance Sheet

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Shh. Funds 1,902 2,491 3,494 4,350 4,622 4,724 4,823 5,837 5,953 6,198
Non Curr. Liab. 927 2,505 1,995 2,303 4,142 3,861 3,299 2,924 2,238 2,823
Curr. Liab. 2,175 2,824 3,285 2,738 5,202 5,165 5,454 4,892 4,415 5,447
Minority Int. 0 0 0 0 1
Equity & Liab. 5,004 7,820 8,775 9,392 13,967 13,751 13,577 13,653 12,606 14,468
Non Curr. Assets 1,600 3,768 4,086 4,513 8,705 8,714 8,596 8,130 7,312 9,139
Curr. Assets 3,404 4,051 4,680 4,879 5,262 5,038 4,979 5,522 5,165 5,314
Misc. Exp. not W/O
Total Assets 5,004 7,820 8,775 9,392 13,967 13,751 13,577 13,653 12,606 14,468

Torrent Pharmaceuticals Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-06 Rs. Cr. TTM
Net Sales 4,653 6,667 5,816 5,950 7,673 7,939 8,005 8,508 9,620 9,864
Other Income 286 229 223 307 64 121 57 197 63 49
Total Income 4,939 6,896 6,039 6,257 7,736 8,061 8,061 8,705 9,683 9,913
Total Expenditure -3,633 -3,937 -4,438 -4,609 -5,696 -5,769 -5,524 -6,077 -6,796 -6,943
PBIDT 1,306 2,959 1,601 1,648 2,040 2,292 2,537 2,628 2,887 2,970
Interest -175 -184 -206 -308 -504 -451 -353 -255 -333 -381
Depreciation -191 -238 -307 -409 -618 -654 -658 -662 -707 -743
Taxation -189 -610 -155 -253 -125 -162 -274 -449 -602 -586
Exceptional Items -194 -357 -485
PAT 751 1,733 934 678 436 1,025 1,252 777 1,245 1,260
Minority Interest 0 0 0 0 0
Share Associate
Other Related Items
Consolidated Net Profit 751 1,733 934 678 436 1,025 1,252 777 1,245 1,260
Adjusted EPS 22 51 28 20 13 30 37 23 37 37

Torrent Pharmaceuticals Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 599 810 2,742 1,009 894 1,798 1,393 2,005 1,803 2,368
Cash Fr. Inv. -356 -2,162 -838 -787 -4,707 -241 199 -449 -197 -2,415
Cash Fr. Finan. 86 1,212 -1,435 -193 3,417 -1,314 -1,549 -1,651 -1,781 77
Net Change 330 -140 469 29 -395 242 42 -95 -175 30
Cash & Cash Eqvt 955 865 1,050 1,068 702 940 662 573 398 509

Torrent Pharmaceuticals Ltd. Shareholding Pattern

9 Qtrs 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%)
Promoter 71.25 71.25 71.25 71.25 71.25 71.25 71.25 71.25 71.25
Public 28.75 28.75 28.75 28.75 28.75 28.75 28.75 28.75 28.75
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Torrent Pharmaceuticals Ltd. Announcements

Sat, 30 Sep 2023
Announcement under Regulation 30 (LODR)-Change in Management
Intimation regarding Change in Senior Management Personnel of the Company
Fri, 29 Sep 2023
Closure of Trading Window
Intimation of the Closure of Trading Window
Thu, 21 Sep 2023
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of Share Certificates

Torrent Pharmaceuticals Ltd. Technical Scans

Fri, 29 Sep 2023
Higher Delivery Quantity Higher Delivery Quantity
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity
Close Crossing Last Week High Close Crossing Last Week High
Closing Above Previous High Closing Above Previous High

Torrent Pharmaceuticals Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 278,106.92 1,159.10 +2.4%
Divi's Laboratories Ltd. 99,942.28 3,761.95 +2.7%
Cipla Ltd. 95,813.38 1,189.75 +2.2%
Dr. Reddy's Laboratories Ltd. 93,178.48 5,595.35 +3.1%
Apollo Hospitals Enterprise Ltd. 73,867.93 5,149.95 +2.5%
Mankind Pharma Ltd. 71,831.52 1,793.15 +1.6%
Zydus Lifesciences Ltd. 62,265.74 615.15 +2.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 32.97 1,159.10 +2.4%
Divi's Laboratories Ltd. Consolidated 2023-06 67.60 3,761.95 +2.7%
Cipla Ltd. Consolidated 2023-06 30.87 1,189.75 +2.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 19.76 5,595.35 +3.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 110.76 5,149.95 +2.5%
Mankind Pharma Ltd. Consolidated 2023-03 56.04 1,793.15 +1.6%
Zydus Lifesciences Ltd. Consolidated 2023-06 24.62 615.15 +2.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-06 4.79 1,159.10 +2.4%
Divi's Laboratories Ltd. Consolidated 2023-06 7.61 3,761.95 +2.7%
Cipla Ltd. Consolidated 2023-06 3.95 1,189.75 +2.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-06 3.80 5,595.35 +3.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-06 11.81 5,149.95 +2.5%
Mankind Pharma Ltd. Consolidated 2023-03 5.87 1,793.15 +1.6%
Zydus Lifesciences Ltd. Consolidated 2023-06 3.34 615.15 +2.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,159.10 +2.4%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,761.95 +2.7%
Cipla Ltd. Consolidated 2023-03 0.02 1,189.75 +2.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 5,595.35 +3.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 5,149.95 +2.5%
Mankind Pharma Ltd. Consolidated 2023-03 0.02 1,793.15 +1.6%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 615.15 +2.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,159.10 +2.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,761.95 +2.7%
Cipla Ltd. Consolidated 2023-03 12.85 1,189.75 +2.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,595.35 +3.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,149.95 +2.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,793.15 +1.6%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 615.15 +2.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,159.10 +2.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,761.95 +2.7%
Cipla Ltd. Consolidated 2023-03 12.85 1,189.75 +2.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 5,595.35 +3.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 5,149.95 +2.5%
Mankind Pharma Ltd. Consolidated 2023-03 19.27 1,793.15 +1.6%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 615.15 +2.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,159.10 +2.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,761.95 +2.7%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,189.75 +2.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 5,595.35 +3.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 5,149.95 +2.5%
Mankind Pharma Ltd. Consolidated 2023-03 8,749.43 1,793.15 +1.6%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 615.15 +2.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,159.10 +2.4%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,761.95 +2.7%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,189.75 +2.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 5,595.35 +3.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 5,149.95 +2.5%
Mankind Pharma Ltd. Consolidated 2023-03 1,309.68 1,793.15 +1.6%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 615.15 +2.1%

Torrent Pharmaceuticals Ltd. FAQ's

What is Torrent Pharma share price?

Can I buy Torrent Pharma shares now?

What is the Dividend Yield of Torrent Pharma?

What is the Market Cap of Torrent Pharma?

What are the key metrics to analyse Torrent Pharma?

What is the 52 Week High and Low of Torrent Pharma?

What is the trend of Torrent Pharma share price?